• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.使用设计探针探究蛋白质精氨酸脱亚氨酶(PAD1、-2和-4)的活性位点
ACS Med Chem Lett. 2013 Jan 15;4(2):249-53. doi: 10.1021/ml300377d. eCollection 2013 Feb 14.
2
Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.蛋白精氨酸脱亚氨酶(PADs):蛋白质瓜氨酸化的生化和化学生物学。
Acc Chem Res. 2019 Mar 19;52(3):818-832. doi: 10.1021/acs.accounts.9b00024. Epub 2019 Mar 7.
3
Monomeric Form of Peptidylarginine Deiminase Type I Revealed by X-ray Crystallography and Small-Angle X-ray Scattering.通过X射线晶体学和小角X射线散射揭示的I型肽基精氨酸脱亚氨酶的单体形式
J Mol Biol. 2016 Jul 31;428(15):3058-73. doi: 10.1016/j.jmb.2016.06.018. Epub 2016 Jul 5.
4
Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?肽基精氨酸脱亚氨酶(PAD)的选择性抑制:作为一种有前景的治疗策略,它能否控制多种炎症性疾病?
Inflammopharmacology. 2023 Apr;31(2):731-744. doi: 10.1007/s10787-023-01149-5. Epub 2023 Feb 17.
5
Development of a highly sensitive fluorescence probe for peptidyl arginine deiminase (PAD) activity.开发一种用于肽基精氨酸脱亚氨酶(PAD)活性的高灵敏度荧光探针。
Bioorg Med Chem Lett. 2019 Apr 1;29(7):923-928. doi: 10.1016/j.bmcl.2019.01.032. Epub 2019 Jan 25.
6
Peptidylarginine Deiminase and Alzheimer's Disease.肽基精氨酸脱亚氨酶与阿尔茨海默病
J Alzheimers Dis. 2022;85(2):473-484. doi: 10.3233/JAD-215302.
7
Optimization and characterization of a pan protein arginine deiminase (PAD) inhibitor一种泛蛋白精氨酸脱亚氨酶(PAD)抑制剂的优化与表征
8
Development of a fluorescent probe for detection of citrulline based on photo-induced electron transfer.基于光诱导电子转移的瓜氨酸检测荧光探针的研制
Bioorg Med Chem Lett. 2018 Mar 1;28(5):969-973. doi: 10.1016/j.bmcl.2018.01.026. Epub 2018 Feb 10.
9
Halogen Bonding Increases the Potency and Isozyme Selectivity of Protein Arginine Deiminase 1 Inhibitors.卤素键增强了蛋白质精氨酸脱亚氨酶 1 抑制剂的效力和同工酶选择性。
Angew Chem Int Ed Engl. 2019 Sep 2;58(36):12476-12480. doi: 10.1002/anie.201906334. Epub 2019 Aug 1.
10
Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.精氨酸残基的甲基化在体外会干扰肽基精氨酸脱亚氨酶的瓜氨酸化作用。
J Mol Biol. 2007 Apr 6;367(4):1118-29. doi: 10.1016/j.jmb.2007.01.054. Epub 2007 Jan 25.

引用本文的文献

1
Molecular Mechanism of Protein Arginine Deiminase 2: A Study Involving Multiple Microsecond Long Molecular Dynamics Simulations.蛋白质精氨酸脱亚氨酶 2 的分子机制:涉及多个微秒长分子动力学模拟的研究。
Biochemistry. 2022 Jul 5;61(13):1286-1297. doi: 10.1021/acs.biochem.2c00158. Epub 2022 Jun 23.
2
Protein Arginine Methylation and Citrullination in Epigenetic Regulation.蛋白质精氨酸甲基化与瓜氨酸化在表观遗传调控中的作用
ACS Chem Biol. 2016 Mar 18;11(3):654-68. doi: 10.1021/acschembio.5b00942. Epub 2015 Dec 31.

本文引用的文献

1
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.瓜氨酸肽基精氨酸脱亚氨酶抑制物可逆转多发性硬化症小鼠模型中的蛋白质高瓜氨酸化和疾病。
Dis Model Mech. 2013 Mar;6(2):467-78. doi: 10.1242/dmm.010520. Epub 2012 Nov 1.
2
Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.抗癌肽基精氨酸脱亚氨酶(PAD)抑制剂调节自噬通量和哺乳动物雷帕霉素靶蛋白复合物 1 活性。
J Biol Chem. 2012 Jul 27;287(31):25941-53. doi: 10.1074/jbc.M112.375725. Epub 2012 May 17.
3
Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.合成并筛选含卤乙酰胺基的文库,以鉴定 PAD4 选择性抑制剂。
ACS Chem Biol. 2012 Jan 20;7(1):160-5. doi: 10.1021/cb200258q. Epub 2011 Oct 21.
4
The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.N-α-(2-羧基)苯甲酰基-N(5)-(2-氟-1-亚氨基乙基)-l-鸟氨酸酰胺(o-F-脒基)和 N-α-(2-羧基)苯甲酰基-N(5)-(2-氯-1-亚氨基乙基)-l-鸟氨酸酰胺(o-Cl-脒基)作为第二代蛋白质精氨酸脱亚氨酶(PAD)抑制剂的发展。
J Med Chem. 2011 Oct 13;54(19):6919-35. doi: 10.1021/jm2008985. Epub 2011 Sep 16.
5
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.PAD1、3 和 4 的底物特异性和动力学研究鉴定出了蛋白精氨酸脱亚氨酶 3 的有效且选择性抑制剂。
Biochemistry. 2010 Jun 15;49(23):4852-63. doi: 10.1021/bi100363t.
6
Born-Oppenheimer ab initio QM/MM molecular dynamics simulations of the hydrolysis reaction catalyzed by protein arginine deiminase 4.应用 Born-Oppenheimer 从头算量子力学/分子力学分子动力学模拟研究蛋白质精氨酸脱亚氨酶 4 催化的水解反应。
J Phys Chem B. 2009 Dec 31;113(52):16705-10. doi: 10.1021/jp9080614.
7
Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease.肽基精氨酸脱亚氨酶介导的翻译后瓜氨酸化在散发性克雅氏病发病机制中的作用。
Acta Neuropathol. 2010 Feb;119(2):199-210. doi: 10.1007/s00401-009-0625-x. Epub 2009 Dec 16.
8
An improved synthesis of haloaceteamidine-based inactivators of protein arginine deiminase 4 (PAD4).基于卤代乙脒的蛋白质精氨酸脱亚氨酶4(PAD4)失活剂的改进合成方法。
Tetrahedron Lett. 2008 Jul 7;49(28):4383-4385. doi: 10.1016/j.tetlet.2008.05.021.
9
Active site cysteine is protonated in the PAD4 Michaelis complex: evidence from Born-Oppenheimer ab initio QM/MM molecular dynamics simulations.在PAD4米氏复合物中活性位点半胱氨酸被质子化:来自玻恩-奥本海默从头算量子力学/分子力学分子动力学模拟的证据。
J Phys Chem B. 2009 Sep 24;113(38):12750-8. doi: 10.1021/jp903173c.
10
Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis.在感染瘙痒病的小鼠大脑中,上调的肽基精氨酸脱氨酶2导致瓜氨酸化蛋白的积累:其在发病机制中的可能作用。
Am J Pathol. 2008 Oct;173(4):1129-42. doi: 10.2353/ajpath.2008.080388. Epub 2008 Sep 11.

使用设计探针探究蛋白质精氨酸脱亚氨酶(PAD1、-2和-4)的活性位点

Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.

作者信息

Bello Angelica M, Wasilewski Ewa, Wei Lianhu, Moscarello Mario A, Kotra Lakshmi P

机构信息

Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada ; Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada ; Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto , Toronto, Ontario, M5S 3M2, Canada.

Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada ; Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada.

出版信息

ACS Med Chem Lett. 2013 Jan 15;4(2):249-53. doi: 10.1021/ml300377d. eCollection 2013 Feb 14.

DOI:10.1021/ml300377d
PMID:24900657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4027443/
Abstract

Protein arginine deiminases (PADs) are involved in a number of cellular pathways, and they catalyze the transformation of peptidyl arginine residue into a citrulline as part of post-translational modifications. To understand ligand preferences, a group of probe molecules were investigated against PAD1, PAD2, and PAD4. These probe molecules carried a well-known covalent modifier of the catalytic cysteine residue, 2-chloroacetamidine moiety, which was tethered to an α-amino acid via a carbon linker. The chain length for the linker varied from 0 to 4. Time-dependent assays indicated that 2-chloroacetamidine (2CA) with no linker inhibited all PAD enzymes with a similar trend in the second-order rate constants, although with poor affinity. Among the other three probe molecules, compound 3 with a three-carbon linker exhibited the best second-order rate constants for optimal ligand reactivity with the binding site. These analyses provide insights into the relative patterns of covalent inactivation of PAD isozymes and the design of novel inhibitors targeting PAD enzymes as potential therapeutic targets.

摘要

蛋白质精氨酸脱亚氨酶(PADs)参与多种细胞途径,作为翻译后修饰的一部分,它们催化肽基精氨酸残基转化为瓜氨酸。为了解配体偏好,研究了一组针对PAD1、PAD2和PAD4的探针分子。这些探针分子带有催化性半胱氨酸残基的著名共价修饰剂2-氯乙脒部分,该部分通过碳连接子与α-氨基酸相连。连接子的链长从0到4不等。时间依赖性分析表明,没有连接子的2-氯乙脒(2CA)以相似的趋势抑制所有PAD酶,尽管亲和力较差,但二级速率常数相似。在其他三个探针分子中,具有三碳连接子的化合物3表现出最佳的二级速率常数,以实现与结合位点的最佳配体反应性。这些分析为PAD同工酶共价失活的相对模式以及靶向PAD酶作为潜在治疗靶点的新型抑制剂的设计提供了见解。